Corporate information

Official name
Boehringer Ingelheim Venture Fund GmbH
Also known as
BIVF

Fund terms

Funding rounds


Investment activity status
Active investor

Selected investments

Displaying 1 - 1 of 1
Profile Country Date Funding
NBE-Therapeutics AG Biotech company focused on developing antibody-based treatments for cancer patients. Series B

Current team

Past employees

Selected Products / Customers

Financials